September 7, 2018

Around the nation: Hospital-led drug company names former Amgen exec CEO

Daily Briefing

    The new drug company on Wednesday announced it will call itself Civica Rx and produce 14 generic drugs to sell by 2019, in today's hospital and health industry news from Florida, Texas, and Utah.

    • Florida: Mayo Clinic Jacksonville on Wednesday announced two expansions totaling over $144 million. The first will be a $106 million addition to Mayo North that will add eight ORs as well as procedural space for a number of departments, and the second will be a $38 million parking garage at Mayo North that will add 25,000 square feet of retail space and more. The first project is expected to be completed by 2021, while the second is expected to be completed by 2020 (Colburn, Jacksonville Business Journal, 9/5).

    • Texas: HCA Healthcare has named Jim Brown CEO of North Cypress Medical Center in Houston. Brown previously served as the chief development officer at HCA's Gulf Coast Division and as SVP and CEO of ambulatory services for Memorial Hermann Health System (Vartorella, Becker's Hospital Review, 9/5).

    • Utah: Earlier this year, several leading health systems announced their intention to form a nonprofit drug company—and on Wednesday they unveiled the company's name, Civica Rx, and CEO, Martin VanTrieste, a former Amgen executive. The new venture, which includes Intermountain Healthcare, Ascension, Trinity Health, and SSM Health, aims to produce 14 generic drugs to sell to one-third of U.S. hospitals by next year (WestHealth release, 9/6; Baker, "Vitals," Axios, 9/6; Ellison, Becker's Hospital Review, 9/6) .

    Learn more: How to ensure seamless leadership transitions

    We spoke with an array of HR executives and discovered eight key insights your organization can use to build a strong, diverse executive team ready to meet current and future challenges. To learn more, read our briefing about how to ensure seamless leadership transitions.

    Download Now

    X
    Cookies help us improve your website experience. By using our website, you agree to our use of cookies.